Rare diseases
Investigational molecules
Locations
Evaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy
BelgiumAssessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder
BulgariaStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
FinlandStudy on Reduction of Toxicant Levels in Blood through Combined Digestive Decontamination with Activated Charcoal and Intestinal Purge for Intubated Patients with Major Poisoning in Intensive Care
FranceStudy on Atorvastatin's Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer
ItalyEfficacy of 177Lu-DOTATATE as Adjuvant Therapy After Surgery for Stage III Small Intestinal Neuroendocrine Tumors
GermanyStudy of Telisotuzumab Adizutecan for Adults with Colorectal Cancer Who Have Positive Circulating Tumor DNA After Treatment but No Visible Cancer on Scans
BelgiumEvaluating 68Ga-FAPI-46 PET/CT Scanning for Improved Diagnosis in Patients with Pancreatic Cancer or Bile Duct Cancer Eligible for Curative Treatment
FranceClinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments
AustriaStudy on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature
FranceStudy of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma
AustriaStudy on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
